Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study

  1. Casasnovas, C.
  2. Ruiz, M.
  3. Schlüter, A.
  4. Naudí, A.
  5. Fourcade, S.
  6. Veciana, M.
  7. Castañer, S.
  8. Albertí, A.
  9. Bargalló, N.
  10. Johnson, M.
  11. Raymond, G.V.
  12. Fatemi, A.
  13. Moser, A.B.
  14. Villarroya, F.
  15. Portero-Otín, M.
  16. Artuch, R.
  17. Pamplona, R.
  18. Pujol, A.
Journal:
Neurotherapeutics

ISSN: 1878-7479,  1933-7213

Year of publication: 2019

Volume: 16

Issue: 4

Pages: 1167-1182

Type: Article

DOI: 10.1007/S13311-019-00735-2 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus